Bio-Techne (TECH) Accumulated Expenses (2010 - 2026)

Bio-Techne's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $17.7 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 26.03% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $17.7 million (down 26.03% YoY), while the FY2025 annual figure was $25.7 million, up 3.12% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $17.7 million, down from $45.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $62.0 million in Q2 2022, with the low at $13.8 million in Q3 2022.
• The 5-year median for Accumulated Expenses is $25.7 million (2025), against an average of $30.2 million.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses sank 75.98% in 2023, then jumped 183.31% in 2024.
• Bio-Techne's Accumulated Expenses stood at $28.6 million in 2022, then grew by 15.23% to $33.0 million in 2023, then slipped by 16.52% to $27.5 million in 2024, then jumped by 63.48% to $45.0 million in 2025, then plunged by 60.73% to $17.7 million in 2026.
• Business Quant data shows TECH's Accumulated Expenses at $17.7 million in Q1 2026, $45.0 million in Q4 2025, and $43.6 million in Q3 2025.